Zelda Therapeutics to Test Formulations against Pancreatic Cancer
Company Secretary Appointment
Sleep disorder clinical trials update
Zelda Therapeutics Enters Into Collaboration Agreement with Prestigious Telethon Kids Institute
Significant Anti-Cancer Effect Observed in Pre-Clinical Studies
Zelda Expands Intellectual Property Portfolio
Zelda Therapeutics debuts on ASX
Investor Presentation Nov 2016
19 Jan 2016 – Q&A Proactive Investors